Login / Signup

Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases.

Shouzhi YangJing FuWenhao QinRuimin WangMingye GuYida HuangWanshan LiuHaiyang SuXiaoyu XuWei ChenAyizekeranmu YimingBing HuLin HuangKun QianHong-Yang Wang
Published in: Hepatology (Baltimore, Md.) (2024)
Our findings confirmed the improved diagnostic capabilities of BileMet assay in a clinical setting. If applied, the BileMet assay enables intraoperative testing and fast medical decision-making for cases with suspected malignancy where brush cytology detection fails to support malignancy, ultimately reducing the economic burden by over 90%.
Keyphrases